Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,801 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Moderate-intensity statin plus ezetimibe vs high-intensity statin according to baseline LDL-C in the treatment of atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING randomized trial.
Lee B, Hong SJ, Rha SW, Heo JH, Hur SH, Choi HH, Kim KJ, Kim JH, Kim HK, Kim U, Choi YJ, Lee YJ, Lee SJ, Ahn CM, Ko YG, Kim BK, Choi D, Hong MK, Jang Y, Kim JS. Lee B, et al. Among authors: kim kj, kim u, kim hk, kim bk, kim js, kim jh. Atherosclerosis. 2023 Dec;386:117373. doi: 10.1016/j.atherosclerosis.2023.117373. Epub 2023 Nov 10. Atherosclerosis. 2023. PMID: 37995599 Clinical Trial.
Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial.
Lee SJ, Cha JJ, Choi WG, Lee WS, Jeong JO, Choi S, Cho YH, Park W, Yoon CH, Lee YJ, Hong SJ, Ahn CM, Kim BK, Ko YG, Choi D, Hong MK, Jang Y, Hong SJ, Kim JS; RACING Investigators. Lee SJ, et al. JAMA Cardiol. 2023 Sep 1;8(9):853-858. doi: 10.1001/jamacardio.2023.2222. JAMA Cardiol. 2023. PMID: 37531130 Clinical Trial.
Intravascular imaging-guided percutaneous coronary intervention in patients with acute myocardial infarction and cardiogenic shock.
Joh HS, Lee SH, Jo J, Kim HK, Lim WH, Kim HL, Seo JB, Chung WY, Kim SH, Zo JH, Kim MA, Kim MC, Kim JH, Hong YJ, Ahn YK, Jeong MH, Hur SH, Kim DI, Chang K, Park HS, Bae JW, Jeong JO, Park YH, Yun KH, Yoon CH, Kim Y, Hwang JY, Kim HS, Hong D, Kwon W, Choi KH, Park TK, Yang JH, Song YB, Hahn JY, Choi SH, Gwon HC, Lee JM; KAMIR Investigators. Joh HS, et al. Among authors: kim hk, kim hl, kim ma, kim sh, kim di, kim mc, kim hs, kim y, kim jh. Rev Esp Cardiol (Engl Ed). 2024 Apr 10:S1885-5857(24)00125-7. doi: 10.1016/j.rec.2024.03.009. Online ahead of print. Rev Esp Cardiol (Engl Ed). 2024. PMID: 38609042 English, Spanish.
Prognosis after discontinuing renin angiotensin aldosterone system inhibitor for heart failure with restored ejection fraction after acute myocardial infarction.
Lee SH, Rhee TM, Shin D, Hong D, Choi KH, Kim HK, Park TK, Yang JH, Song YB, Hahn JY, Choi SH, Chae SC, Cho MC, Kim CJ, Kim JH, Kim HS, Gwon HC, Jeong MH, Lee JM; KAMIR-NIH Investigators. Lee SH, et al. Among authors: kim hk, kim cj, kim hs, kim jh. Sci Rep. 2023 Mar 2;13(1):3539. doi: 10.1038/s41598-023-30700-1. Sci Rep. 2023. PMID: 36864119 Free PMC article.
Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Non-ST-Elevation Myocardial Infarction.
Kim CH, Lee SH, Kim HK, Kim MC, Kim JH, Hong YJ, Ahn YK, Jeong MH, Hur SH, Kim DI, Chang K, Park HS, Bae JW, Jeong JO, Park YH, Yun KH, Yoon CH, Kim Y, Hwang JY, Kim HS, Choi KH, Park TK, Yang JH, Song YB, Hahn JY, Choi SH, Gwon HC, Lee JM; KAMIR-NIH Investigators. Kim CH, et al. Among authors: kim hk, kim di, kim mc, kim hs, kim y, kim jh. Circ J. 2024 Apr 11. doi: 10.1253/circj.CJ-24-0129. Online ahead of print. Circ J. 2024. PMID: 38599833 Free article.
QFR Assessment and Prognosis After Nonculprit PCI in Patients With Acute Myocardial Infarction.
Lee SH, Hong D, Shin D, Kim HK, Park KH, Choo EH, Kim CJ, Kim MC, Hong YJ, Ahn SG, Doh JH, Lee SY, Park SD, Lee HJ, Kang MG, Koh JS, Cho YK, Nam CW, Joh HS, Choi KH, Park TK, Yang JH, Song YB, Choi SH, Jeong MH, Gwon HC, Hahn JY, Lee JM; FRAME-AMI Investigators. Lee SH, et al. Among authors: kim hk, kim mc, kim cj. JACC Cardiovasc Interv. 2023 Oct 9;16(19):2365-2379. doi: 10.1016/j.jcin.2023.08.032. JACC Cardiovasc Interv. 2023. PMID: 37821181 Clinical Trial.
Angiographic Severity of the Nonculprit Lesion and the Efficacy of Fractional Flow Reserve-Guided Complete Revascularization in Patients With AMI: FRAME-AMI Substudy.
Seung J, Choo EH, Kim CJ, Kim HK, Park KH, Lee SH, Kim MC, Hong YJ, Ahn SG, Doh JH, Lee SY, Park SD, Lee HJ, Kang MG, Koh JS, Cho YK, Nam CW, Koo BK, Lee BK, Yun KH, Hong D, Joh HS, Choi KH, Park TK, Lee JM, Yang JH, Song YB, Choi SH, Gwon HC, Hahn JY; FRAME-AMI Investigators. Seung J, et al. Among authors: kim hk, kim mc, kim cj. Circ Cardiovasc Interv. 2024 Jan;17(1):e013611. doi: 10.1161/CIRCINTERVENTIONS.123.013611. Epub 2023 Nov 6. Circ Cardiovasc Interv. 2024. PMID: 37929584 Free article.
Cost-Effectiveness of Fractional Flow Reserve-Guided Treatment for Acute Myocardial Infarction and Multivessel Disease: A Prespecified Analysis of the FRAME-AMI Randomized Clinical Trial.
Hong D, Lee SH, Lee J, Lee H, Shin D, Kim HK, Park KH, Choo EH, Kim CJ, Kim MC, Hong YJ, Jeong MH, Ahn SG, Doh JH, Lee SY, Don Park S, Lee HJ, Kang MG, Koh JS, Cho YK, Nam CW, Choi KH, Park TK, Yang JH, Song YB, Choi SH, Gwon HC, Guallar E, Cho J, Hahn JY, Kang D, Lee JM; FRAME-AMI Investigators. Hong D, et al. Among authors: kim hk, kim mc, kim cj. JAMA Netw Open. 2024 Jan 2;7(1):e2352427. doi: 10.1001/jamanetworkopen.2023.52427. JAMA Netw Open. 2024. PMID: 38270954 Free PMC article.
5,801 results